Transcriptomics

Dataset Information

0

ATG5-regulated MCP-1 production in myeloid cells selectively modulates anti-malarial CD4+ Th1 responses


ABSTRACT: Induction of parasite-specific CD4+ Th1 cell responses is a promising strategy for designing effective blood-stage malaria vaccines; however, the underlying regulatory mechanisms remain largely unknown. This study demonstrated that ATG5 deficiency in myeloid cells can significantly inhibit the growth of rodent blood-stage malarial parasites by enhancing parasite-specific CD4+ Th1 cell responses. This effect was independent of ATG5-mediated canonical and non-canonical autophagy. Mechanistically, ATG5 deficiency promoted myeloid cell (Ly6G-CD11b+F4/80-) survival and subsequently increased MCP-1 production in parasite-infected mice. Ly6G-CD11b+F4/80- cell-derived MCP-1 interacted with CCR2 on CD4+ Th1 cells for their optimized responses through the JAK2/STAT4 pathway. Notably, recombinant MCP-1 significantly improved parasite-specific CD4+ Th1 responses of the whole-killed blood-stage vaccine. Conclusively, our study highlights the previously unrecognized role of ATG5 in modulating myeloid cell survival via MCP-1 production, which selectively promotes CD4+ Th1 cell responses. Our findings provide new insights into the development of effective antimalarial vaccines.

ORGANISM(S): Mus musculus

PROVIDER: GSE239405 | GEO | 2023/12/16

REPOSITORIES: GEO

Similar Datasets

2024-03-01 | GSE228461 | GEO
2021-02-26 | GSE165223 | GEO
2011-03-10 | E-GEOD-24102 | biostudies-arrayexpress
2017-08-09 | PXD005064 | Pride
2017-04-10 | GSE84586 | GEO
2022-10-25 | GSE212622 | GEO
2020-07-08 | GSE119733 | GEO
2024-03-09 | GSE227476 | GEO
2012-04-22 | E-GEOD-29164 | biostudies-arrayexpress
2012-04-23 | GSE29164 | GEO